Understanding women's views on endometrial cancer and prevention strategies
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
This study talks to women about what they think and know about endometrial cancer and prevention options to help improve future prevention efforts.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06409052 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather pilot data on women's attitudes and knowledge regarding endometrial cancer and potential prevention strategies. It involves conducting qualitative interviews with women who have been diagnosed with endometrial cancer, abnormal uterine bleeding, or endometrial hyperplasia, as well as those without any diagnosis. The goal is to better understand their perspectives and inform future prevention efforts.
Who should consider this trial
Good fit: Ideal candidates include women aged 18 and older who are either diagnosed with endometrial cancer, abnormal uterine bleeding, or endometrial hyperplasia, or those without any diagnosis but willing to participate.
Not a fit: Patients who are not fluent in English or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance awareness and inform strategies to reduce the risk of endometrial cancer among women.
How similar studies have performed: While this study focuses on qualitative insights, similar studies have successfully gathered patient perspectives on cancer prevention, indicating a potential for valuable findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer 2. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia 3. Women without a diagnosis of endometrial cancer or endometrial hyperplasia 4. Women must be at least 18 years or age 5. Women must be able to read, write, and speak English 6. Women must be willing and able to provide written informed consent Exclusion Criteria:
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Larissa Meyer, MD — M.D. Anderson Cancer Center
- Study coordinator: Larissa Meyer, MD
- Email: lmeyer@mdanderson.org
- Phone: (713) 745-0973
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.